U.S. COVID vaccine for children under 5 delayed by at least 2 months
By Michael Erman (Reuters) – A U.S. decision on Pfizer and BioNTech’s COVID-19 vaccine for infants and children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration (FDA) said it needed more data. The FDA had planned to decide on the vaccine based …
U.S. COVID vaccine for children under 5 delayed by at least 2 months Read More »










